Fluorescence in situ hybridization (FISH) analysis is an FDA-approved, urine-based marker that assists in diagnosis and surveillance of invasive urothelial cancer. This article provides an overview and case study demonstrating the clinical use of this analysis. As a systematic review of non-randomized and randomized clinical trials, this article provides Level I evidence.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
applicability fish
4
fish test
4
test bladder
4
bladder cancer
4
cancer fluorescence
4
fluorescence situ
4
situ hybridization
4
hybridization fish
4
fish analysis
4
analysis fda-approved
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!